Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DelNS1-2019-nCoV-RBD-OPT1 as Booster in BNT162b2-Vaccinated Adults
NCT05200741Phase 2Unknown
- Sponsor
- The University of Hong Kong
- Start
- Feb 2022
- Primary completion
- Feb 2024
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Pneucolin in coronavirus disease 2019 (COVID-19), sponsored by The University of Hong Kong. Status: unknown.
02
Drugs
Pneucolin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05200741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05200741.